Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD

3.07  -0.03 (-0.97%)

After market: 3.0799 +0.01 (+0.32%)

Fundamental Rating

2

Taking everything into account, OSUR scores 2 out of 10 in our fundamental rating. OSUR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OSUR has reported negative net income.
In the past year OSUR had a positive cash flow from operations.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a decent Return On Assets value of -6.98%, OSUR is doing good in the industry, outperforming 65.24% of the companies in the same industry.
OSUR has a better Return On Equity (-8.06%) than 67.91% of its industry peers.
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Gross Margin, with a value of 41.98%, OSUR is doing worse than 65.24% of the companies in the same industry.
OSUR's Gross Margin has declined in the last couple of years.
OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
The number of shares outstanding for OSUR has been increased compared to 5 years ago.
OSUR has a better debt/assets ratio than last year.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.73 indicates that OSUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
OSUR has a Altman-Z score of 2.73. This is in the better half of the industry: OSUR outperforms 66.31% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, OSUR is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.73
ROIC/WACCN/A
WACC9.06%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

OSUR has a Current Ratio of 12.34. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Current ratio of 12.34 is amongst the best of the industry. OSUR outperforms 94.12% of its industry peers.
A Quick Ratio of 10.94 indicates that OSUR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.94, OSUR belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.34
Quick Ratio 10.94
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -191.30%.
OSUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.94%.
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%

3.2 Future

The Earnings Per Share is expected to grow by 29.63% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -3.71% on average over the next years.
EPS Next Y-192.27%
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%
EPS Next 5Y29.63%
Revenue Next Year-31.27%
Revenue Next 2Y-14.32%
Revenue Next 3Y-7.32%
Revenue Next 5Y-3.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A cheap valuation may be justified as OSUR's earnings are expected to decrease with -19.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (7/14/2025, 5:20:32 PM)

After market: 3.0799 +0.01 (+0.32%)

3.07

-0.03 (-0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners89.56%
Inst Owner Change0%
Ins Owners4.71%
Ins Owner Change21.22%
Market Cap229.64M
Analysts78
Price Target4.59 (49.51%)
Short Float %4.4%
Short Ratio4.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.32%
Min EPS beat(2)-142.2%
Max EPS beat(2)-0.43%
EPS beat(4)2
Avg EPS beat(4)-13.01%
Min EPS beat(4)-142.2%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)-13.93%
EPS beat(12)8
Avg EPS beat(12)199.37%
EPS beat(16)8
Avg EPS beat(16)98.7%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.56%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)2.18%
Revenue beat(8)7
Avg Revenue beat(8)6.63%
Revenue beat(12)11
Avg Revenue beat(12)11.17%
Revenue beat(16)14
Avg Revenue beat(16)9.75%
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)-28.12%
EPS NQ rev (3m)-20.59%
EPS NY rev (1m)-30.7%
EPS NY rev (3m)-20.16%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-7.88%
Revenue NY rev (1m)0.94%
Revenue NY rev (3m)-4.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF 254.3
P/B 0.58
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.39%
SpS2.16
BVpS5.3
TBVpS4.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.98%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.08%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.34
Quick Ratio 10.94
Altman-Z 2.73
F-Score5
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y-192.27%
EPS Next 2Y-51.49%
EPS Next 3Y-19.5%
EPS Next 5Y29.63%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%
Revenue Next Year-31.27%
Revenue Next 2Y-14.32%
Revenue Next 3Y-7.32%
Revenue Next 5Y-3.71%
EBIT growth 1Y-342.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89.45%
EBIT Next 3Y44.24%
EBIT Next 5Y25.91%
FCF growth 1Y93.03%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y116.72%
OCF growth 3YN/A
OCF growth 5Y22.81%